VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $206,000 | -4.2% | 10,820 | -15.0% | 0.06% | -12.5% |
Q1 2018 | $215,000 | -4.0% | 12,730 | -13.7% | 0.07% | -1.4% |
Q4 2017 | $224,000 | -19.7% | 14,750 | -5.2% | 0.07% | -20.7% |
Q3 2017 | $279,000 | -46.8% | 15,560 | -51.6% | 0.09% | -38.7% |
Q2 2017 | $524,000 | -0.9% | 32,160 | -14.9% | 0.15% | +19.0% |
Q1 2017 | $529,000 | -12.3% | 37,800 | 0.0% | 0.13% | -8.7% |
Q4 2016 | $603,000 | -5.9% | 37,800 | -1.9% | 0.14% | -9.2% |
Q3 2016 | $641,000 | – | 38,540 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |